Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Harga Moderna Inc saat ini di pasar adalah Rp 1.009.534,41, dengan volume perdagangan 24 jam sebesar Rp 5,07T. Kapitalisasi pasar aset ini adalah Rp 400,56T, setelah bergerak 0.31% dalam satu hari terakhir.
Moderna Inc tertokenisasi diperdagangkan di Rp 1.000.890,43, dengan kapitalisasi pasar tertokenisasi sebesar Rp 979,98M dan volume perdagangan 24 jam sebesar Rp 10,87B. Aset tertokenisasi ini telah bergerak -5.34% dalam 24 jam terakhir.